Evidence map›Paper›PMID 25202013›Full record

ArticleThe Journal of biological chemistry2014

Medroxyprogesterone acetate differentially regulates interleukin (IL)-12 and IL-10 in a human ectocervical epithelial cell line in a glucocorticoid receptor (GR)-dependent manner.

Renate Louw-du Toit, Janet P Hapgood, Donita Africander

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 34 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Glucocorticoid receptors: finding the middle ground.The Journal of clinical investigation · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Renate Louw-du ToitFrom the Department of Biochemistry, University of Stellenbosch, Private Bag X1, Matieland 7602 and.
Janet P Hapgoodthe Department of Molecular and Cell Biology, University of Cape Town, Rondebosch 7700, South Africa.
Donita AfricanderFrom the Department of Biochemistry, University of Stellenbosch, Private Bag X1, Matieland 7602 and drho@sun.ac.za.
Stellenbosch University · ZA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Medroxyprogesterone acetate (MPA), designed to mimic the actions of the endogenous hormone progesterone (P4), is extensively used by women as a contraceptive and in hormone replacement therapy. However, little is known about the steroid receptor-mediated molecular mechanisms of action of MPA in the female genital tract. In this study, we investigated the regulation of the pro-inflammatory cytokine, interleukin (IL)-12, and the anti-inflammatory cytokine IL-10, by MPA versus P4, in an in vitro cell culture model of the female ectocervical environment. This study shows that P4 and MPA significantly increase the expression of the IL-12p40 and IL-12p35 genes, whereas IL-10 gene expression is suppressed in a dose-dependent manner. Moreover, these effects were abrogated when reducing the glucocorticoid receptor (GR) levels with siRNA. Using a combination of chromatin immunoprecipitation (ChIP), siRNA, and re-ChIP assays, we show that recruitment of the P4- and MPA-bound GR to the IL-12p40 promoter requires CCAAT enhancer-binding protein (C/EBP)-β and nuclear factor κB (NFκB), although recruitment to the IL-10 promoter requires signal transducer and activator of transcription (STAT)-3. These results suggest that both P4 and MPA may modulate inflammation in the ectocervix via this genomic mechanism.

Indexed as

CCAAT-Enhancer-Binding Protein-betaCell LineCervix UteriContraceptive Agents, FemaleEpithelial CellsFemaleGene Expression RegulationGenomicsHumansInflammationInterleukin-10Interleukin-12 Subunit p35Interleukin-12 Subunit p40Medroxyprogesterone AcetateNF-kappa BProgestinsCCAAT-Enhancer-Binding Protein-betaCEBPB protein, humanContraceptive Agents, FemaleIL10 protein, humanIL12A protein, humanIL12B protein, humanInterleukin-10Interleukin-12 Subunit p35Interleukin-12 Subunit p40Medroxyprogesterone AcetateNF-kappa BProgestinsReceptors, GlucocorticoidRNA, Small InterferingSTAT3 protein, humanSTAT3 Transcription FactorCervical EpitheliumContraceptionCytokinesGene RegulationGlucocorticoidGlucocorticoid ReceptorInflammationMedroxyprogesterone AcetateProgesteroneProgestin

Identifiers

PMID25202013
PMCPMC4223317
OpenAlexW2080610075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.